Hormonal effects on the mammary gland of postmenopausal nonhuman primates

Breast Disease

Volumn 24, Issue 1, 2005, Pages 59-70

  Cline, J Mark ^a   Wood, Charles E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BIOLOGICAL MARKER; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GESTAGEN; GROWTH HORMONE; ISOFLAVONE DERIVATIVE; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; NORETHISTERONE ACETATE; PERGOLIDE; PHYTOESTROGEN; PLACEBO; PROGESTERONE; PROGESTERONE RECEPTOR; RECOMBINANT GROWTH HORMONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN; TAMOXIFEN; TIBOLONE;

ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CANCER GROWTH; CANCER RISK; DISEASE MODEL; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; HISTOPATHOLOGY; HORMONE ACTION; HORMONE METABOLISM; HORMONE SUBSTITUTION; MACACA; MAMMARY GLAND; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; MONOTHERAPY; NONHUMAN; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR;

EID: 33747367508     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/bd-2006-24105     Document Type: Article

References (106)

1. F.J. Agate, Jr., The growth and secretory activity of the mammary glands of the pregnant Rhesus monkey (Macaca mulatta) following hypophysectomy, Am J Anat 90 (1952), 257-283.
2. C. Albert, M. Vallee, G. Beaudry, A. Belanger and D.W. Hum, The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes, Endocrinology 140 (1999), 3292-3302.
3. E. Allen, The menstrual cycle of the monkey, Macaca rhesus: Observations on normal animals, the effects of removal of the ovaries and the effects of injections of ovarian and placental extracts into the spayed animals, Contributions to Embryology, The Carnegie Institute of Washington 19 (1927), 1-44.
4. M.A. Attia, Cyclic changes in genital organs and vaginal cytology in cynomolgus monkeys (Macaca fascicularis), DTW - Deutsche Tierarztliche Wochenschrift 105 (1998), 399-404.
5. O. Barbier and A. Belanger, The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation, J Steroid Biochem Mol Bio 85 (2003), 235-245.
6. B. Belanger, A. Belanger, F. Labrie, A. Dupont, L. Cusan and G. Monfette, Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men, J Steroid Biochem 32 (1989), 695-698.
7. B. Belanger, J. Couture, S. Caron, P. Bodou, J. Fiet and A. Belanger, Production and secretion of C-19 steroids by rat and guinea pig adrenals, Steroids 55 (1990), 360-365.
8. F.L. Bellino and P.M. Wise, Nonhuman primate models of menopause workshop, Biol Reprod 68 (2003), 10-18.
9. V. Beral, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet 362 (2003), 419-427.
10. H. Borgerink and J.M. Cline, Triple immunolabeling in a single section of mammary gland using Ki67-MIB1, ER alpha, and ER beta antibodies, J Histotechnol 27 (2004), 1-3.
11. A. Brodie, Aromatase and its inhibitors - an overview, J Steroid Biochem Mol Biol 40 (1991), 255-261.
12. A.M. Cameron and L.T. Faulkin, Jr., Subgross evaluation of the nonhuman primate mammary gland: Method and initial observations, J Med Primatol 3 (1974), 298-310.
13. S.T. Chao, C.J. Omiecinski, M.J. Namkung, S.D. Nelson, B.H. Dvorchik and M.R. Juchau, Catechol estrogen formation in placental and fetal tissues of humans, macaques, rats and rabbits, Developmental Pharmacology & Therapeutics 2 (1981), 1-16.
14. G. Cherite, H.J. Kloosterboer and J.R. Pasqualini, Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells, Anticancer Res 17 (1A) (1997), 135-140.
15. C.S. Choong, J.A. Kemppainen and E.M. Wilson, Evolution of the primate androgen receptor: A structural basis for disease, Journal of Molecular Evolution 47 (1998), 334-342.
16. R.B. Clarke, A. Howell, C.S. Potten and E. Anderson, Dissociation between steroid receptor expression and cell proliferation in the human breast, Cancer Res 57 (1997), 4987-4991.
17. M. Clemons and P. Goss, Estrogen and the risk of breast cancer, N Engl J Med 344 (2001), 276-285.
18. J.M. Cline, T.C. Register and T.B. Clarkson, Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys, Menopause 9 (2002), 422-429.
19. J.M. Cline, G. Soderqvist, T.C. Register, J.K. Williams, M.R. Adams and B. Von Schoultz, Assessment of hormonally active agents in the reproductive tract of female nonhuman primates, Toxicol Pathol 29 (2001), 84-90.
20. J.M. Cline, G. Soderqvist, E. von Schoultz, L. Skoog and B. von Schoultz, Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques, Breast Cancer Res Treat 48 (1998), 221-229.
21. J.M. Cline, G. Soderqvist, E. von Schoultz, L. Skoog and B. von Schoultz, Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques, Amer J Obstet Gynec 174 (1996), 93-100.
22. J.M. Cline and C.E. Wood, Assessing the mammary gland of nonhuman primates, Birth Defects Research (2006), in press.
23. K.M. Cookson, The parenteral toxicity of Cyclofem, ontraception 49 (1994), 335-345.
24. Y. Daniel, M. Inbar, A. Bar-Am, M.R. Peyser and J.B. Lessing, The effects of tamoxifen treatment on the endometrium, Fertil Steril 65 (1996), 1083-1089.
25. J.S. Daviau and J.G. Trupkiewicz, Pituitary adenoma with galactorrhea in an adult male cynomolgus macaque (Macaca fascicularis), Contemp Top Lab Anim Sci 40 (2001), 57-59.
26. M. De Lemos, Safety issues of soy phytoestrogens in breast cancer patients, J Clin Oncol 20 (2002), 3040-3041; author reply 3041-3042.
27. C. Dimitrakakis, J. Zhou, J. Wang et al., A physiologic role for testosterone in limiting estrogenic stimulation of the breast, Menopause 10 (2003), 292-298.
28. V.A. Drill and P.L. Golway, Effect of ethynodiol diacetate with ethinyl estradiol on the mammary glands of rhesus monkeys: A preliminary report, J Natl Cancer Inst 60 (1978), 1169-1170.
29. V.A. Drill, D.P. Martin, E.R. Hart and R.G. McConnell, Effect of oral contraceptives on the mammary glands of Rhesus monkeys: A preliminary report, J Natl Cancer Inst 52 (1974), 1655-1657.
30. V.A. Drill, An overview of studies on estrogens, oral contraceptives and breast cancer, Prog Drug Res 25 (1981), 159-187.
31. D.M. Duffy, D.L. Hess and R.L. Stouffer, Acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to rhesus monkeys at the midluteal phase of the menstrual cycle: Evidence for possible regulation of the primate corpus luteum by progesterone, Journal of Clinical Endocrinology & Metabolism 79 (1994), 1587-1594.
32. A.M. Duncan, B.E. Merz-Demlow, X. Xu, W.R. Phipps and M.S. Kurzer, Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer, Cancer Epidemiol Biomarkers Prev 9 (2000), 581-586.
33. F. Durocher, J. Simard, J. Ouellette, V. Richard, F. Labrie and G. Pelletier, Localization of BRCA1 gene expression in adult cynomolgus monkey tissues, J Histochem Cytochem 45 (1997), 1173-1188.
34. J. Fitzgerald, F. de la Iglesia and E.I. Goldenthal, Ten-year oral toxicity study with Norlestrin in rhesus monkeys, J Toxicol Erviron Health 10 (1982), 879-896.
35. D. Foth and J.M. Cline, Effects of mammalian and plant estrogens on mammary glands and uteri of macaques, Amer J Clin Nutr 68(Suppl) (1998), 1413S-1417S.
36. R.G. Geil and J.K. Lamar, FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey, J Toxicol Environ Health 3 (1977), 179-193.
37. C.F. Geschickter and C.G. Hartman, Mammary response to prolonged estrogenic stimulation in the monkey, Cancer 12 (1959), 767-781.
38. C.F. Geschickter, D. Lewis and C.G. Hartman, Tumors of the breast related to the oestrin hormone, Am J Cancer 21 (1934), 828-859.
39. S.R. Goldstein and N. Nanavati, Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study, Am J Obstet Gynecol 187 (2002), 521-527.
40. S.E. Hankinson, W.C. Willett, J.E. Manson, G.A. Colditz, D.J. Hunter, D. Spiegelman, R.L. Barbieri and F.E. Speizer, Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90 (1998), 1292-1299.
41. D.F. Hargreaves, C.S. Potten, C. Harding, C. Harding, L.E. Shaw, M.S. Morton, S.A. Roberts, A. Howell and N.J. Bundred, Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast, J Clin Endocrinol Metab 84 (1999), 4017-4024.
42. D.C. Herbert, J. Schuppler, A. Poggel, P. Gunzel and M.F. El Etreby, Effect of cyproterone acetate on prolactin secretion in the female Rhesus monkey, Cell Tissue Res 183 (1977), 51-60.
43. E. Isaksson, H. Wang, L. Sahlin, B. von Schoultz, B. Masironi, E. von Schoultz and J.M. Cline, Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen, Breast 11 (2002), 295-300.
44. E. Isaksson, H. Wang, L. Sahlin, B. von Schoultz, J.M. Cline and E. von Schoultz, Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques, Breast Cancer Res Treat 79 (2003), 233-239.
45. A. Jordan, Toxicology of depot medroxyprogesterone acetate, Contraception 49 (1994), 189-201.
46. J.O. Jorgensen, J.J. Christensen, E. Vestergaard, S. Fisker, P. Ovesen and J.S. Christiansen, Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults, Horm Res 64(Suppl 2) (2005), 37-40.
47. K.D. Jorgensen, O. Svendsen, R.J. Greenough et al., Biosynthetic human growth hormone: Subchronic toxicity studies in rats and monkeys, Pharmacol Toxicol 62 (1988), 329-333.
48. Y.H. Ju, C.D. Allred, K.F. Allred, K.L. Karko, D.R. Doerge and W.G. Helferich, Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice, J Nutr 131(11) (2001), 2957-2962.
49. R. Kaaks, F. Berrino, T. Key, S. Rinaldi, L. Dossus, C. Biessy, G. Secreto, P. Amiano, S. Bingham, H. Boeing, H.B. Bueno de Mesquita, J. Chang-Claude, F. Clavel-Chapelon, A. Fournier, C.H. van Gils, C.A. Gonzalez, A.B. Gurrea, E. Critselis, K.T. Khaw, V. Krogh, P.H. Lahmann, G. Nagel, A. Olsen, N.C. Onland-Moret, K. Overvad, D. Palli, S. Panico, P. Peeters, J.R. Quiros, A. Roddam, A. Thiebaut, A. Tjonneland, M.D. Chirlaque, A. Trichopoulou, D. Trichopoulos, R. Tumino, P. Vineis, T. Norat, P. Ferrari, N. Slimani and E. Riboli, Serum sex steroids in premenopausal women and breast cancer risk withm the European Prospective Investigation into Cancer and Nutrition (EPIC), J Natl Cancer Inst 97(10) (2005), 755-765.
50. J.W. Kemnitz, E.B. Roecker, A.L. Haffa, J. Pinheiro, I. Kurzman, J.J. Ramsey and E.G. MacEwen, Serum dehydroepiandrosterone sulfate concentrations across the life span of laboratory-housed rhesus monkeys, J Med Primatol 29 (2000), 330-337.
51. T. Key, P. Appleby, I. Barnes and G. Reeves, Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies, J Natl Cancer Inst 94 (2002), 606-616.
52. D.L. Kleinberg, W. Niemann, E. Flamm, P. Cooper, G. Babitsky and Q. Valensi, Primate mammary development. Effects of hypophysectomy, prolactin inhibition, and growth hormone administration, J Clin Invest 75 (1985), 1943-1950.
53. H.J. Kloosterboer, Tissue-selective effects of tibolone on the breast, Maturitas 49(1) (2004), S5-S15.
54. Y. Kobayashi, N. Tagawa, K. Muraoka, Y. Okamoto and M. Nishida, Participation of endogenous dehydroepiandrosterone and its sulfate in the pathology of collagen-induced arthritis in mice, Biol Pharm Bull 26 (2003), 1596-1599.
55. F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.X. Lin and G. Pelletier, Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone, Endocr Rev 24 (2003), 152-182.
56. F. Labrie, Intracrinology, Mol Cell Endocrinol 78 1991), C113-118.
57. M.A. Lane, D.K. Ingram, S.S. Ball and G.S. Roth, Dehydroepiandrosterone sulfate: A biomarker of primate aging lowed by calorie restriction, J Clin Endocrinol Metab 82 (1997), 2093-2096.
58. A.E. Lee and W.R. Dukelow, Tamoxifen effects on mammary gland morphology and ovarian activity in Macaca fascicularis, J Med Primatol 10 (1981), 102-109.
59. E.O. Lillie, L. Bernstein and G. Ursin, The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer, Breast Cancer Res 5(3) (2003), 164-173.
60. C.L. Magness, P.C. Fellin, M.J. Thomas, M.J. Korth, M.B. Agy, S.C. Proll, M. Fitzgibbon, C.A. Scherer, D.G. Miner, M.G. Katze and S.P. Iadonato, Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and human, Genome Biol 6 (2005), R60.
61. S. Malaivijitnond and P. Varavudhi, Evidence for morphine-induced galactorrhea in male cynomolgus monkeys, J Med Primatol 27 (1998), 1-9.
62. C. Martel, M.H. Melner, D. Gagne, J. Simard and F. Labrie, Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey, Mol Cell Endocrinol 104 (1994), 103-111.
63. G. Maskarinec, A.A. Franke, A.E. Williams, S. Hebshi, C. Oshiro, S. Murphy and F.Z. Stanczyk, Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women, Cancer Epidemiol Biomarkers Prev 13 (2004), 1736-1744.
64. B.E. McKenzie, Guidelines and requirements for the evaluation of contraceptive steroids, Toxicol Pathol 17 (1989), 377-384.
65. D. Medina, Biological and molecular characteristics of the premalignant mouse mammary gland, Biochim Biophys Acta 1603 (2002), 1-9.
66. S.A. Missmer, A.H. Eliassen, R.L. Barbieri and S.E. Hankinson, Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women, J Natl Cancer Inst 96 (2004), 1856-1865.
67. F. Moinfar, M. Okcu, O. Tsybrovskyy, P. Regitnig, S.F. Lax, W. Weybora, M. Ratschek, F.A. Tavassoli and H. Denk, Androgen receptors frequently are expressed in breast carcinomas: Potential relevance to new therapeutic strategies, Cancer 98(4) (2003), 703-711.
68. NAMS expert panel, The role of testosterone therapy in postmenopausal women: Position statement of The North American Menopause Society, Menopause 12 (2005), 497-511.
69. C.B. Newman, H. Cosby, H.G. Friesen et al., Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary gland, Proc Natl Acad Sci USA 84 (1987), 8110-8114.
70. S.T. Ng, J. Zhou, O.O. Adesanya, J. Wang, D. LeRoith and C.A. Bondy, Growth hormone treatment induces mammary gland hyperplasia in aging primates, Nat Med 3 (1997), 1141-1144.
71. I.O. Obasanjo, J.M. Cline, S. Schmotzer and D.S. Weaver, Nandrolone decanoate causes pathologic changes in the uterus of surgically postmenopausal female cynomolgus macaques, Menopause 5 (1998), 163-168.
72. N. Orentreich, J.L. Brind, R.L. Rizer and J.H. Vogelman, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood, J Clin Endocrinol Metab 59 (1984), 551-555.
73. D.L. Page, P.A. Schuyler, W.D. Dupont, R.A. Jensen, W.D. Plummer, Jr. and J.F. Simpson, Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: A retrospective cohort study, Lancet 361 (2003), 125-129.
74. C.Y. Pau, K.Y. Pau and H.G. Spies, Putative estrogen receptor beta and alpha mRNA expression in male and female rhesus macaques, Mol Cell Endocrinol 146 (1998), 59-68.
75. A. Pavlicek, V.N. Noskov, N. Kouprina, J.C. Barrett, J. Jurka and V. Larionov, Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition, Hum Mol Genet 13 (2004), 2737-2751.
76. G. Pelletier, Localization of androgen and estrogen receptors in rat and primate tissues, Histol Histopathol 15 (2000), 1261-1270.
77. N.L. Petrakis, S. Barnes, E.B. King, J. Lowenstein, J. Wiencke, M.M. Lee, R. Miike, M. Kirk and L. Coward, Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women, Cancer Epidemiol Biomarkers Prev 5 (1996), 785-794.
78. R. Poulin, D. Baker and F. Labrie, Androgens inhibit basal and estrogeninduced cell proliferation in the ZR-75-1 breast cancer cell line, Breast Cancer Res Treat 12 (1988), 213-225.
79. A.K. Remick, C.E. Wood, J.A. Cann, M.K. Gee, E.A. Feiste, N.D. Kock and J.M. Cline, Histologic and immunohistochemical characterization of spontaneous pituitary adenomas in 13 cynomolgus macaques (Macaca fascicularis), Vet Pathol (2006), in press.
80. J.E. Rossouw, G.L. Anderson, R.L. Prentice et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial, JAMA 288 (2002), 321-333.
81. J. Russo, Y.F. Hu, X. Yang and I.H. Russo, Developmental, cellular, and molecular basis of human breast cancer, J Natl Cancer Inst Monogr (2000), 17-37.
82. A. Schultz, Fetal growth and development of the rhesus monkey, Carnegie Contributions to Embryology 26 (1937), 71-97.
83. D.C. Skegg, E.A. Noonan, C. Paul, G.F. Spears, O. Meirik and D.B. Thomas, Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies, JAMA 273 (1995), 799-804.
84. E.G. Snyderwine, R.J. Turesky, K.W. Turteltaub, et al., Metabolism of food-derived heterocyclic amines in nonhuman primates, Mutat Res 376 (1997), 203-210.
85. W. Somboonporn and S.R. Davis, National Health and Medical Research Council. Testosterone effects on the breast: Implications for testosterone therapy for women, Endocr Rev 25(3) (2004), 374-388.
86. K. Sonne-Hansen and A.E. Lykkesfeldt, Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line, J Steroid Biochem Mol Biol 93(1) (2005), 25-34.
87. H. Speert, The normal and experimental development of the mammary gland of the rhesus monkey with some pathologic correlations, Contributions to Embryology, The Carnegie Institute of Washington 32 (1948), 9-65.
88. L. Speroff, The Million Women Study and breast cancer, Maturitas 46(1) (2003), 1-6.
89. P. Stute, T.C. Register, R. Blair and J.M. Cline, Effects of tibolone on estrogen biosynthesis in the mammary tissue of postmenopausal monkeys, Menopause (2006), in press.
90. P. Stute, C.E. Wood, J.R. Kaplan and J.M. Cline, Cyclic changes in the mammary gland of cynomolgus macaques, Fertil Steril 82(S3) (2004), 1160-1170.
91. F.A. Tavassoli, H.W. Casey and H.J. Norris, The morphologic effects of synthetic reproductive steroids on the mammary gland of rhesus monkeys. Mestranol, ethynerone, mestranolethynerone, chloroethynyl norgestrel-mestranol, and anagestone acetate-mestranol combinations, Am J Pathol 131 (1988), 213-234.
92. A. Tsubura, T. Hatano, S. Hayama and S. Morii, Immunophenotypic difference of keratin expression in normal mammary glandular cells from five different species, Acta Anat (Basel) 140 (1991), 287-293.
93. S.S. Tworoger, A.H. Eliassen, B. Rosner, P. Sluss and S.E. Hankinson, Plasma prolactin concentrations and risk of postmenopausal breast cancer, Cancer Res 64(18) (2004), 6814-6819.
94. H. Uno, Age-related pathology and biosenescent markers in captive rhesus macques, Age 20 (1997), 1-13.
95. M.G. Valerio, Comparative aspects of contraceptive steroids: Effects observed in the monkey, Toxicol Pathol 17 (1989), 401-410.
96. M.D. Vardy, T.R. Gardner, F. Cosman, R.J. Scotti, M.S. Mikhail, A.O. Preiss-Bloom, J.K. Williams, J.M. Cline and R. Lindsay, The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model, Am J Obstet Gynecol. 192 (2005), 1741-1751.
97. T.T. Wang, N. Sathyamoorthy and J.M. Phang, Molecular effects of genistein on estrogen receptor mediated pathways, Carcinogenesis. 17(2) (1996), 271-275.
98. M. Warner, Mammary Pathology, in: Aging in Nonhuman Primates, D. Dowden, ed., Van Nostrand Reinhold, New York, 1979.
99. M.E. Wilson, T.P. Gordon, C.G. Rudman and J.M. Tanner, Effects of a natural versus artificial environment on the tempo of maturation in female rhesus monkeys, Endocrinol 123 (1988), 2653-2661.
100. C.E. Wood, J.M. Cline, M.S. Anthony, T.C. Register and J.R. Kaplan, Adrenocortical Effects of Oral Estrogens and Soy Isoflavones in Female Monkeys, J Clin Endocrinol Metab 89 (2004), 2319-2325.
101. C.E. Wood, T.C. Register, M.S. Anthony and J.M. Cline, Breast and Uterine Effects of Soy Isoflavones and Conjugated Equine Estrogens in Postmenopausal Female Monkeys, J Clin Endocrinol Metab 89 (2004), 3462-3468.
102. C.E. Wood, T.C. Register, A.A. Franke, M.S. Anthony and J.M. Cline, Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast, Cancer Res 66(2) (2006), 1241-1249.
103. C.E. Wood, A. Usborne, R. Tarara, M.F. Starost, L.R. Hill, M. Wilkinson, E.A. Feiste and J.M. Cline, Hyperplastic and neoplastic lesions of the mammary gland in macaques, Vet Pathol (2006), in press.
104. L. Yan and E. Spitznagel, A meta-analysis of soy consumption and risk of breast cancer in women, Int J Cancer Prev 1 (2004), 281-293.
105. J. Zhou, K. Anderson, M. Bievre, S. Ng and C.A. Bondy, Primate mammary gland insulin-like growth factor system: Cellular localization and regulation by sex steroids, J Investig Med 49 (2001), 47-55.
106. J. Zhou, S. Ng, O. Adesanya-Famuiya, K. Anderson and C.A. Bondy, Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression, FASEB J 14 (2000), 1725-1730.